Avenzo

Avenzo Therapeutics

This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.

Adcendo ApS

The company develops antibody-drug conjugates to treat patients with advanced solid tumors and cancers that have high unmet medical needs.

Avenge Bio

This biotechnology firm develops cell-based immunotherapies for patients with solid tumours, specifically targeting metastatic peritoneal cancers like ovarian cancer.

Avistone Pharmaceuticals

The company develops and manufactures precision oncology medicines, specifically small-molecule targeted therapies for patients with lung cancer and other solid tumours.

ArriVent

This biopharmaceutical company develops and commercialises oncology therapeutics, including targeted medicines and antibody-drug conjugates, to treat patients with difficult-to-treat cancers globally.

Adcendo

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.

ImmunoQuest Therapeutics

This preclinical biopharmaceutical company develops antibody-drug conjugates for patients with treatment-resistant, metastatic breast cancer and other solid tumours.

Abalos Therapeutics

This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.